| Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis N Ahmad, SD Ahuja, OW Akkerman, JWC Alffenaar, LF Anderson, ... The Lancet 392 (10150), 821-834, 2018 | 417 | 2018 |
| Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study K Schnippel, N Ndjeka, G Maartens, G Meintjes, I Master, N Ismail, ... The Lancet Respiratory Medicine 6 (9), 699-706, 2018 | 230 | 2018 |
| The impact and cost of scaling up GeneXpert MTB/RIF in South Africa G Meyer-Rath, K Schnippel, L Long, W MacLeod, I Sanne, W Stevens, ... PloS one 7 (5), e36966, 2012 | 180 | 2012 |
| Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis N Ndjeka, F Conradie, K Schnippel, J Hughes, N Bantubani, H Ferreira, ... The International Journal of Tuberculosis and Lung Disease 19 (8), 979-985, 2015 | 158 | 2015 |
| Rapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care: an evaluation of a pilot program in South Africa B Larson, K Schnippel, B Ndibongo, T Xulu, A Brennan, L Long, MP Fox, ... Journal of acquired immune deficiency syndromes (1999) 61 (2), e13, 2012 | 125 | 2012 |
| High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen N Ndjeka, K Schnippel, I Master, G Meintjes, G Maartens, R Romero, ... European Respiratory Journal 52 (6), 2018 | 95 | 2018 |
| Scaling up Xpert MTB/RIF technology: the costs of laboratory‐ vs. clinic‐based roll‐out in South Africa K Schnippel, G Meyer‐Rath, L Long, W MacLeod, I Sanne, WS Stevens, ... Tropical Medicine & International Health 17 (9), 1142-1151, 2012 | 70 | 2012 |
| How to estimate the cost of point-of-care CD4 testing in program settings: an example using the Alere Pima™ analyzer in South Africa B Larson, K Schnippel, B Ndibongo, L Long, MP Fox, S Rosen PloS one 7 (4), e35444, 2012 | 66 | 2012 |
| Costs of inpatient treatment for multi‐drug‐resistant tuberculosis in S outh A frica K Schnippel, S Rosen, K Shearer, N Martinson, L Long, I Sanne, ... Tropical Medicine & International Health 18 (1), 109-116, 2013 | 64 | 2013 |
| Point-of-care Xpert® MTB/RIF for smear-negative tuberculosis suspects at a primary care clinic in South Africa A Van Rie, L Page-Shipp, CF Hanrahan, K Schnippel, H Dansey, ... The International journal of tuberculosis and lung disease 17 (3), 368-372, 2013 | 57 | 2013 |
| Adverse drug reactions during drug-resistant TB treatment in high HIV prevalence settings: a systematic review and meta-analysis K Schnippel, C Firnhaber, R Berhanu, L Page-Shipp, E Sinanovic Journal of Antimicrobial Chemotherapy 72 (7), 1871-1879, 2017 | 50 | 2017 |
| Predictors of mortality and treatment success during treatment for rifampicin-resistant tuberculosis within the South African National TB Programme, 2009 to 2011: a cohort … K Schnippel, K Shearer, D Evans, R Berhanu, N Ndjeka International Journal of Infectious Diseases 39, 89-94, 2015 | 47 | 2015 |
| Diagnosing Xpert MTB/RIF-negative TB: Impact and cost of alternative algorithms for South Africa K Schnippel, G Meyer-Rath, L Long, WS Stevens, I Sanne, S Rosen South African Medical Journal 103 (2), 101-106, 2013 | 39 | 2013 |
| Same-day CD4 testing to improve uptake of HIV care and treatment in South Africa: point-of-care is not enough BA Larson, K Schnippel, A Brennan, L Long, T Xulu, T Maotoe, S Rosen, ... AIDS research and treatment 2013, 2013 | 38 | 2013 |
| Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study K Schnippel, RH Berhanu, A Black, C Firnhaber, N Maitisa, D Evans, ... BMC Infectious Diseases 16 (1), 1-10, 2016 | 35 | 2016 |
| Delays, interruptions, and losses from prevention of mother-to-child transmission of HIV services during antenatal care in Johannesburg, South Africa: a cohort analysis K Schnippel, C Mongwenyana, LC Long, BA Larson BMC infectious diseases 15 (1), 1-6, 2015 | 34 | 2015 |
| Estimating implementation and operational costs of an integrated tiered CD4 service including laboratory and point of care testing in a remote health district in South Africa N Cassim, LM Coetzee, K Schnippel, DK Glencross PloS one 9 (12), e115420, 2014 | 34 | 2014 |
| Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa D Evans, T Sineke, K Schnippel, R Berhanu, C Govathson, A Black, ... BMC health services research 18, 1-12, 2018 | 32 | 2018 |
| The impact of adverse events on health-related quality of life among patients receiving treatment for drug-resistant tuberculosis in Johannesburg, South Africa T Sineke, D Evans, K Schnippel, H van Aswegen, R Berhanu, N Musakwa, ... Health and quality of life outcomes 17 (1), 1-15, 2019 | 27 | 2019 |
| Persistently high early mortality despite rapid diagnostics for drug-resistant tuberculosis cases in South Africa K Schnippel, C Firnhaber, N Ndjeka, F Conradie, L Page-Shipp, ... The International Journal of Tuberculosis and Lung Disease 21 (10), 1106-1111, 2017 | 23 | 2017 |
Lawrence LongResearch Assistant Professor, Boston UniversityVerifisert e-postadresse på bu.edu
